ARCALYST ® (rilonacept) is an interleukin-1 blocker indicated for: Treatment of recurrent pericarditis (RP) and reduction in risk of recurrence in adults and pediatric patients 12 years and older.

May 1, 2025 · Arcalyst is used to treat some of the symptoms of rare genetic conditions such as Familial Cold Auto-inflammatory Syndrome (FCAS) or Muckle-Wells Syndrome (MWS). FCAS and MWS are …

ARCALYST (rilonacept) is the only FDA-approved therapy to treat recurrent pericarditis and reduce the risk of recurrence in patients 12 years and older.

Find step-by-step administration instructions and FAQs for ARCALYST®, a once-weekly subcutaneous injection for the treatment of recurrent pericarditis.

ARCALYST (rilonacept) is an interleukin-1 blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and...

Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells …

Sep 15, 2024 · Find patient medical information for Arcalyst (rilonacept) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

FDA has approved Arcalyst (rilonacept) injection to treat recurrent pericarditis and reduce the risk of recurrence in adults and children 12 years and older.

Jun 3, 2024 · ARCALYST® (rilonacept) is an interleukin-1 blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory …

May 16, 2025 · Arcalyst (rilonacept) is a prescription medication that's used to treat adults and children with certain rare inflammatory conditions, including cryopyrin-associated periodic syndromes …